Report Scope & Overview:
Drug Discovery Outsourcing Market Size was valued at $3.6 Billion in 2021 and is projected to reach $7.4 Billion by 2031, growing at a CAGR of 7.5% from 2022 to 2031.
The global Drug Discovery Outsourcing market is expected to experience significant growth due to various factors such as increasing demand for the product, the presence of key market players, and advancements in technology. This report provides an in-depth analysis of the market size, growth trends, pricing structure, production, value chain analysis, and regional assessment. The report also offers insights into company profiling and emerging product lines.
Market Overview: The drug discovery outsourcing market involves the outsourcing of various stages of the drug discovery process to contract research organizations (CROs) and other service providers. This outsourcing allows pharmaceutical and biotechnology companies to access specialized expertise, reduce costs, and accelerate the drug development timeline.
Market Drivers:
Cost Efficiency: Outsourcing drug discovery services can be cost-effective for pharmaceutical companies, as they can leverage the expertise of specialized service providers without the need for heavy investments in infrastructure and personnel.
Expertise Access: CROs often have specialized knowledge and advanced technologies in specific areas of drug discovery, enabling clients to benefit from the latest scientific advancements.
Flexibility: Outsourcing provides companies with flexibility in managing their drug development pipelines. They can scale their operations up or down based on project requirements.
Time Savings: Drug discovery outsourcing can accelerate the drug development process by leveraging the efficiency and expertise of CROs, potentially bringing new drugs to market faster.
Challenges: While there are benefits to drug discovery outsourcing, challenges may include communication issues, intellectual property concerns, and the need for effective collaboration between the outsourcing partner and the client.
Market Trends:
Growing Outsourcing in Early-Stage Research: Companies are increasingly outsourcing early-stage research activities, including target identification and validation, as they seek to focus internal resources on later-stage development and commercialization.
Technological Advancements: The adoption of advanced technologies, such as artificial intelligence, machine learning, and high-throughput screening, is impacting the drug discovery outsourcing landscape, enabling more efficient and data-driven processes.
Increased Collaboration Models: Collaborative partnerships and risk-sharing models between pharmaceutical companies and CROs are becoming more prevalent in the drug discovery outsourcing sector.
Global Drug Discovery Outsourcing Market: By Company
• Charles River Laboratories
• Thermo Fisher Scientific
• DomaineX
• Evotec A.G.
• GenScript
• Abbott Laboratories
• GVkBiosciences
• Agilent Technologies
• Shimadzu
• Bio-Rad
• PerkinElmer
• AMRI Global
• LabCorp
• WuXi AppTec
Global Drug Discovery Outsourcing Market: By Type
• Small Molecules
• Biologics
Global Drug Discovery Outsourcing Market: By Application
• Hospitals and Clinics
• Pharmaceutical Companies
• Others
Global Drug Discovery Outsourcing Market: Regional Analysis
The regional analysis of the global Drug Discovery Outsourcing market provides insights into the market's performance across different regions of the world. The analysis is based on recent and future trends and includes market forecast for the prediction period. The countries covered in the regional analysis of the Drug Discovery Outsourcing market report are as follows:
North America: The North America region includes the U.S., Canada, and Mexico. The U.S. is the largest market for Drug Discovery Outsourcing in this region, followed by Canada and Mexico. The market growth in this region is primarily driven by the presence of key market players and the increasing demand for the product.
Europe: The Europe region includes Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe. Germany is the largest market for Drug Discovery Outsourcing in this region, followed by the U.K. and France. The market growth in this region is driven by the increasing demand for the product in the automotive and aerospace sectors.
Asia-Pacific: The Asia-Pacific region includes Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, and Rest of Asia-Pacific. China is the largest market for Drug Discovery Outsourcing in this region, followed by Japan and India. The market growth in this region is driven by the increasing adoption of the product in various end-use industries, such as automotive, aerospace, and construction.
Middle East and Africa: The Middle East and Africa region includes Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of Middle East and Africa. The market growth in this region is driven by the increasing demand for the product in the aerospace and defense sectors.
South America: The South America region includes Argentina, Brazil, and Rest of South America. Brazil is the largest market for Drug Discovery Outsourcing in this region, followed by Argentina. The market growth in this region is primarily driven by the increasing demand for the product in the automotive sector.
| Report Attribute/Metric | Details |
| Market Size 2021 | $3.6 Billion |
| Market Size 2031 | $7.4 Billion |
| Compound Annual Growth Rate (CAGR) | 7.5%(2022-2031) |
| Base Year | 2022 |
| Forecast Period | 2023-2032 |
| Historical Data | 2018-2022 |
| Forecast Units | Value ($ Billion ) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| By Type | • Small Molecules • Biologics |
| By Application | • Hospitals and Clinics • Pharmaceutical Companies |
| Key Companies Profiled | • Charles River Laboratories • Thermo Fisher Scientific • DomaineX • Evotec A.G. • GenScript • Abbott Laboratories • GVkBiosciences • Agilent Technologies • Shimadzu • Bio-Rad • PerkinElmer • AMRI Global • LabCorp • WuXi AppTec |
| Regions and Key Countries Covered | U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America |
| Customization Scope | Available on Request |
Reasons to Purchase Drug Discovery Outsourcing Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Objectives of Drug Discovery Outsourcing Market Study:
The objectives of Drug Discovery Outsourcing market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Drug Discovery Outsourcing market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Frequently Asked Questions
Drug Discovery Outsourcing Market Size was valued at $3.6 Billion in 2021 and is projected to reach $7.4 Billion by 2031, growing at a CAGR of 7.5% from 2022 to 2031.
North America and Europe are the leading regions in the drug discovery outsourcing market, driven by a robust pharmaceutical and biotechnology industry presence.
The increasing complexity of drug discovery, rising R&D costs, and a focus on core competencies are driving the outsourcing market. Challenges include concerns about data security and quality control.
Emerging trends include the adoption of advanced technologies such as artificial intelligence and machine learning, virtual drug discovery models, and an increasing focus on personalized medicine.
The market is poised for continued growth, driven by advancements in technology, increasing R&D activities, and the need for cost-effective solutions. Opportunities lie in expanding service portfolios and geographical reach.
TABLE OF CONTENT
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Discovery Outsourcing Market Size Growth Rate by Type: 2018 VS 2023 VS 2032
1.2.2 Small Molecules
1.2.3 Biologics
1.3 Market by Application
1.3.1 Global Drug Discovery Outsourcing Market Growth by Application: 2018 VS 2023 VS 2032
1.3.2 Hospitals and Clinics
1.3.3 Pharmaceutical Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Discovery Outsourcing Market Perspective (2017-2032)
2.2 Drug Discovery Outsourcing Growth Trends by Region
2.2.1 Global Drug Discovery Outsourcing Market Size by Region: 2018 VS 2023 VS 2032
2.2.2 Drug Discovery Outsourcing Historic Market Size by Region (2017-2023)
2.2.3 Drug Discovery Outsourcing Forecasted Market Size by Region (2023-2032)
2.3 Drug Discovery Outsourcing Market Dynamics
2.3.1 Drug Discovery Outsourcing Industry Trends
2.3.2 Drug Discovery Outsourcing Market Drivers
2.3.3 Drug Discovery Outsourcing Market Challenges
2.3.4 Drug Discovery Outsourcing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Discovery Outsourcing Players by Revenue
3.1.1 Global Top Drug Discovery Outsourcing Players by Revenue (2017-2023)
3.1.2 Global Drug Discovery Outsourcing Revenue Market Share by Players (2017-2023)
3.2 Global Drug Discovery Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Discovery Outsourcing Revenue
3.4 Global Drug Discovery Outsourcing Market Concentration Ratio
3.4.1 Global Drug Discovery Outsourcing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Discovery Outsourcing Revenue in 2022
3.5 Drug Discovery Outsourcing Key Players Head office and Area Served
3.6 Key Players Drug Discovery Outsourcing Product Solution and Service
3.7 Date of Enter into Drug Discovery Outsourcing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Discovery Outsourcing Breakdown Data by Type
4.1 Global Drug Discovery Outsourcing Historic Market Size by Type (2017-2023)
4.2 Global Drug Discovery Outsourcing Forecasted Market Size by Type (2023-2032)
5 Drug Discovery Outsourcing Breakdown Data by Application
5.1 Global Drug Discovery Outsourcing Historic Market Size by Application (2017-2023)
5.2 Global Drug Discovery Outsourcing Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Drug Discovery Outsourcing Market Size (2017-2032)
6.2 North America Drug Discovery Outsourcing Market Growth Rate by Country: 2018 VS 2023 VS 2032
6.3 North America Drug Discovery Outsourcing Market Size by Country (2017-2023)
6.4 North America Drug Discovery Outsourcing Market Size by Country (2023-2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Discovery Outsourcing Market Size (2017-2032)
7.2 Europe Drug Discovery Outsourcing Market Growth Rate by Country: 2018 VS 2023 VS 2032
7.3 Europe Drug Discovery Outsourcing Market Size by Country (2017-2023)
7.4 Europe Drug Discovery Outsourcing Market Size by Country (2023-2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Discovery Outsourcing Market Size (2017-2032)
8.2 Asia-Pacific Drug Discovery Outsourcing Market Growth Rate by Region: 2018 VS 2023 VS 2032
8.3 Asia-Pacific Drug Discovery Outsourcing Market Size by Region (2017-2023)
8.4 Asia-Pacific Drug Discovery Outsourcing Market Size by Region (2023-2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Discovery Outsourcing Market Size (2017-2032)
9.2 Latin America Drug Discovery Outsourcing Market Growth Rate by Country: 2018 VS 2023 VS 2032
9.3 Latin America Drug Discovery Outsourcing Market Size by Country (2017-2023)
9.4 Latin America Drug Discovery Outsourcing Market Size by Country (2023-2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Discovery Outsourcing Market Size (2017-2032)
10.2 Middle East & Africa Drug Discovery Outsourcing Market Growth Rate by Country: 2018 VS 2023 VS 2032
10.3 Middle East & Africa Drug Discovery Outsourcing Market Size by Country (2017-2023)
10.4 Middle East & Africa Drug Discovery Outsourcing Market Size by Country (2023-2032)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Detail
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Drug Discovery Outsourcing Introduction
11.1.4 Charles River Laboratories Revenue in Drug Discovery Outsourcing Business (2017-2023)
11.1.5 Charles River Laboratories Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Drug Discovery Outsourcing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Drug Discovery Outsourcing Business (2017-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 DomaineX
11.3.1 DomaineX Company Detail
11.3.2 DomaineX Business Overview
11.3.3 DomaineX Drug Discovery Outsourcing Introduction
11.3.4 DomaineX Revenue in Drug Discovery Outsourcing Business (2017-2023)
11.3.5 DomaineX Recent Development
11.4 Evotec A.G.
11.4.1 Evotec A.G. Company Detail
11.4.2 Evotec A.G. Business Overview
11.4.3 Evotec A.G. Drug Discovery Outsourcing Introduction
11.4.4 Evotec A.G. Revenue in Drug Discovery Outsourcing Business (2017-2023)
11.4.5 Evotec A.G. Recent Development
11.5 GenScript
11.5.1 GenScript Company Detail
11.5.2 GenScript Business Overview
11.5.3 GenScript Drug Discovery Outsourcing Introduction
11.5.4 GenScript Revenue in Drug Discovery Outsourcing Business (2017-2023)
11.5.5 GenScript Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Detail
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Drug Discovery Outsourcing Introduction
11.6.4 Abbott Laboratories Revenue in Drug Discovery Outsourcing Business (2017-2023)
11.6.5 Abbott Laboratories Recent Development
11.7 GVkBiosciences
11.7.1 GVkBiosciences Company Detail
11.7.2 GVkBiosciences Business Overview
11.7.3 GVkBiosciences Drug Discovery Outsourcing Introduction
11.7.4 GVkBiosciences Revenue in Drug Discovery Outsourcing Business (2017-2023)
11.7.5 GVkBiosciences Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Detail
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Drug Discovery Outsourcing Introduction
11.8.4 Agilent Technologies Revenue in Drug Discovery Outsourcing Business (2017-2023)
11.8.5 Agilent Technologies Recent Development
11.9 Shimadzu
11.9.1 Shimadzu Company Detail
11.9.2 Shimadzu Business Overview
11.9.3 Shimadzu Drug Discovery Outsourcing Introduction
11.9.4 Shimadzu Revenue in Drug Discovery Outsourcing Business (2017-2023)
11.9.5 Shimadzu Recent Development
11.10 Bio-Rad
11.10.1 Bio-Rad Company Detail
11.10.2 Bio-Rad Business Overview
11.10.3 Bio-Rad Drug Discovery Outsourcing Introduction
11.10.4 Bio-Rad Revenue in Drug Discovery Outsourcing Business (2017-2023)
11.10.5 Bio-Rad Recent Development
11.11 PerkinElmer
11.11.1 PerkinElmer Company Detail
11.11.2 PerkinElmer Business Overview
11.11.3 PerkinElmer Drug Discovery Outsourcing Introduction
11.11.4 PerkinElmer Revenue in Drug Discovery Outsourcing Business (2017-2023)
11.11.5 PerkinElmer Recent Development
11.12 AMRI Global
11.12.1 AMRI Global Company Detail
11.12.2 AMRI Global Business Overview
11.12.3 AMRI Global Drug Discovery Outsourcing Introduction
11.12.4 AMRI Global Revenue in Drug Discovery Outsourcing Business (2017-2023)
11.12.5 AMRI Global Recent Development
11.13 LabCorp
11.13.1 LabCorp Company Detail
11.13.2 LabCorp Business Overview
11.13.3 LabCorp Drug Discovery Outsourcing Introduction
11.13.4 LabCorp Revenue in Drug Discovery Outsourcing Business (2017-2023)
11.13.5 LabCorp Recent Development
11.14 WuXi AppTec
11.14.1 WuXi AppTec Company Detail
11.14.2 WuXi AppTec Business Overview
11.14.3 WuXi AppTec Drug Discovery Outsourcing Introduction
11.14.4 WuXi AppTec Revenue in Drug Discovery Outsourcing Business (2017-2023)
11.14.5 WuXi AppTec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Thermo Fisher Scientific
DomaineX
Evotec A.G.
GenScript
Abbott Laboratories
GVkBiosciences
Agilent Technologies
Shimadzu
Bio-Rad
PerkinElmer
AMRI Global
LabCorp
WuXi AppTec
In Vitro Diagnostics Quality Control Market
Global In Vitro Diagnostics Quality Control Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Ileostomy Market
Global Ileostomy Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hypertrophic Cardiomyopathy (HCM) Therapeutics Market
Global Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Human Papillomavirus Vaccine Market
Global Human Papillomavirus Vaccine Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast
Hospital Acquired Pneumonia Drugs Market
Global Hospital Acquired Pneumonia Drugs Market Size, Share, Trends, Growth, Industry Analysis, By Segmentations, Key Players, Revenue, Future Outlook & Forecast